Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption.
about
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-ISUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PMLA Structural Basis for the Assembly and Functions of a Viral Polymer that Inactivates Multiple Tumor SuppressorsFunctional connection between Rad51 and PML in homology-directed repair.Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein.Proteomic analysis of ubiquitin-like posttranslational modifications induced by the adenovirus E4-ORF3 protein.Nuclear domain 10 of the viral aspect.Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formationAggresome formation by the adenoviral protein E1B55K is not conserved among adenovirus species and is not required for efficient degradation of nuclear substratesPhosphorylation drives an apoptotic protein to activate antiapoptotic genes: paradigm of influenza A matrix 1 protein function.The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription.New insights into the role of PML in tumour suppression.Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing.Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodiesPromyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both?Murine gammaherpesvirus 68 encodes a second PML-modifying protein.The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication.Design stars: how small DNA viruses remodel the host nucleus.The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K.Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.Sp100 isoform-specific regulation of human adenovirus 5 gene expression.The human adenovirus 5 L4 promoter is activated by cellular stress response protein p53.Adenovirus E4orf3 targets transcriptional intermediary factor 1γ for proteasome-dependent degradation during infection.PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies.Adenovirus late-phase infection is controlled by a novel L4 promoter.Promyelocytic leukemia protein isoform II inhibits infection by human adenovirus type 5 through effects on HSP70 and the interferon response.Adenovirus E4-ORF3-dependent relocalization of TIF1α and TIF1γ relies on access to the Coiled-Coil motif.The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha.Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription.The Mre11 Cellular Protein Is Modified by Conjugation of Both SUMO-1 and SUMO-2/3 during Adenovirus Infection
P2860
Q24298207-32345C64-D658-4F22-9015-B32A89C3CB5DQ24312113-CE05D808-A686-43FD-B7AC-F25AB25C63F6Q24338995-1D9C47BF-4F33-497C-859C-1943D71856C9Q27674473-379DADEC-2A3A-42B3-9644-67C7BBEEEE35Q31037336-6ED8D425-4B10-4F56-965F-7352A2BE638CQ33751911-83C6E78B-F70D-4B89-8085-B1289DBE4E3BQ34991427-EE7AEF1C-ADE6-4F8E-B551-1A878476ECABQ35047491-96B9E37C-4AFA-4529-A452-2C645FF3E1DCQ36086246-3E1B37CA-9D88-413E-890E-172FF55E7F82Q36216480-1A8348EC-7129-41C0-A73E-F6C13978C8CFQ36759991-7C2F76AC-2501-4F0E-BD2B-EC6D4EC50048Q36850385-DE4CF6C3-B3CE-4017-8BBA-365DE29447ACQ37145192-EA2DE55E-82CC-4E54-AFCA-B6C8FCA4283CQ37173760-4EC1096A-4ACD-4783-95F0-EE737AA68690Q37406026-D00A6A23-6D70-4BC8-9CCF-34700161E326Q37496657-BA2B8946-2704-475C-9872-E17814C97605Q37599336-FDC4CE58-B9C7-4DA0-AE77-BB7BFCBD701AQ37643766-DFACFF4E-67A8-43B4-927F-24370C978F3CQ37808166-1A9D63A4-25D5-411C-A60F-1970734D22A9Q38023415-3E0CB64C-0284-4180-89CC-DACD501460B6Q38880684-BADD9272-32D6-41D8-B137-F5A46A039AEBQ38904410-45311047-E2B8-4730-8EA9-2411AE986CD2Q39016075-C8C78AA3-EB9E-4452-9C2B-B3E740382367Q39106880-59DE33A9-0DF2-4A05-8C48-053151492881Q39421013-E096E4FA-A710-459E-9D62-EF279C68206AQ39617826-46A4590F-B552-43DA-AA13-D78C9C11003DQ39666008-D4FA141F-7218-45E8-ADA9-E52CE5C47E98Q39707314-5BC1BC94-FC91-41BB-99A1-8A1BE3BB6895Q39741495-3E1DF68D-F2DC-41AA-9D77-B3F8A2E1326DQ40095994-341C286A-5C7D-4A90-BC79-454007AA80B8Q40173431-021A7C84-965C-41B3-A6B8-636DCD21FA51Q42019706-BCF423B8-4561-4FF1-81AC-CA307179C9F2Q42022579-C92738C5-D1F8-48BA-B121-929C9BEC4712Q59049206-DD85E5DB-139A-41B2-B5EB-94F5EDDB1084
P2860
Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Interaction of the adenovirus ...... s required for ND10 disruption
@nl
Interaction of the adenovirus ...... required for ND10 disruption.
@ast
Interaction of the adenovirus ...... required for ND10 disruption.
@en
Interaction of the adenovirus ...... required for ND10 disruption.
@en-gb
type
label
Interaction of the adenovirus ...... s required for ND10 disruption
@nl
Interaction of the adenovirus ...... required for ND10 disruption.
@ast
Interaction of the adenovirus ...... required for ND10 disruption.
@en
Interaction of the adenovirus ...... required for ND10 disruption.
@en-gb
prefLabel
Interaction of the adenovirus ...... s required for ND10 disruption
@nl
Interaction of the adenovirus ...... required for ND10 disruption.
@ast
Interaction of the adenovirus ...... required for ND10 disruption.
@en
Interaction of the adenovirus ...... required for ND10 disruption.
@en-gb
P2093
P2860
P921
P1433
P1476
Interaction of the adenovirus ...... s required for ND10 disruption
@en
P2093
Anne Hoppe
John Dimmock
Stephanie J Beech
P2860
P304
P356
10.1128/JVI.80.6.3042-3049.2006
P407
P577
2006-03-01T00:00:00Z